Oct 22, 2021 Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option
Oct 7, 2021 Harbor Custom Development, Inc. Announces Closing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
Oct 4, 2021 Harbor Custom Development, Inc. Announces Pricing of $36 Million Public Offering of Convertible Preferred Shares & Warrants
Sep 17, 2021 EzFill Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
Sep 16, 2021 Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
